Evidence map›Paper›PMID 34455469›Full record

ArticleJournal of neurology2022

When should we consider chronic patients as non-responders to monoclonal antibodies targeting the CGRP pathway?

Claudia Altamura, Sabina Cevoli, Nicoletta Brunelli, Cinzia Aurilia, Luisa Fofi, Gabriella Egeo, Piero Barbanti, Fabrizio Vernieri, GARLIT Study Group collaborators

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Clinical Management of Migraine.Journal of clinical medicine · 2022
    Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Claudia AltamuraHeadache and Neurosonology Unit, Campus Bio-Medico di Roma University Hospital, Via Alvaro del Portillo, 200, 00128, Roma, Italy.ORCID http://orcid.org/0000-0002-5934-5535
Sabina CevoliIRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Nicoletta BrunelliHeadache and Neurosonology Unit, Campus Bio-Medico di Roma University Hospital, Via Alvaro del Portillo, 200, 00128, Roma, Italy.ORCID http://orcid.org/0000-0002-8590-9015
Cinzia AuriliaHeadache and Pain Unit, IRCCS San Raffaele Pisana, Rome, Italy.
Luisa FofiHeadache and Pain Unit, IRCCS San Raffaele Pisana, Rome, Italy.
Gabriella EgeoHeadache and Pain Unit, IRCCS San Raffaele Pisana, Rome, Italy.
Piero BarbantiHeadache and Pain Unit, IRCCS San Raffaele Pisana, Rome, Italy.ORCID http://orcid.org/0000-0002-5670-3755
Fabrizio VernieriHeadache and Neurosonology Unit, Campus Bio-Medico di Roma University Hospital, Via Alvaro del Portillo, 200, 00128, Roma, Italy. f.vernieri@unicampus.it.ORCID http://orcid.org/0000-0002-9594-9336
GARLIT Study Group collaborators
IRCCS Ospedale San Raffaele · ITUniversità Campus Bio-Medico · ITIstituto delle Scienze Neurologiche di Bologna · ITSan Raffaele University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic Agents, ImmunologicalCalcitonin Gene-Related PeptideAntibodies, MonoclonalCalcitonin Gene-Related Peptide Receptor AntagonistsHumansAntibodies, MonoclonalAntineoplastic Agents, ImmunologicalCalcitonin Gene-Related PeptideCalcitonin Gene-Related Peptide Receptor Antagonists

Identifiers

PMID34455469
OpenAlexW3198243989

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.